EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Divergent Role of Statin Use and Intensity in Patients Undergoing Transcatheter Aortic Valve Replacement

Haitham Abu Khadija, Alena Kirzhner, Nizar Abu Hamdeh, Gera Gandelman, Omar Ayyad, Lilian Jofa, Amir Haim, Ramon Cohen, Alex Blatt, Adam Hassan, Ameer Mahamid, Duha Najajra und 6 weitere

Cardiorenal Medicine · 05.06.2026 · 16 (1) · 374-392

DOI: 10.1159/000551694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiorenal Medicine, online erschienen am 05.06.2026. Verfasst von Haitham Abu Khadija und 17 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University, Jerusalem, Israel. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Acute Kidney Injury, Transcatheter Aortic Valve Replacement, Postoperative Complications. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute kidney injury (AKI) and reduced glomerular filtration rate (GFR) are common complications following transcatheter aortic valve replacement (TAVR). Statins may exert renoprotective effects; however, the impact of statin intensity on renal outcomes remains uncertain. This study aimed to evaluate the association between preprocedural statin use and intensity with short-term renal outcomes after TAVR.

Methods

We conducted a retrospective longitudinal cohort study including 810 consecutive patients undergoing TAVR at Kaplan Medical Center between January 2014 and August 2024. Patients were stratified by statin use (users vs. non-users) and statin intensity (high-intensity statins [HISs] vs. low-to-moderate-intensity statins). The primary outcome was 30-day change in estimated GFR (eGFR), categorized as improved, stable, or deteriorated. The secondary outcome was 30-day incidence of AKI. Multinomial logistic regression and Cox proportional hazards models were used, adjusted for baseline and procedural confounders.

Results

Statin use was associated with an increased probability of GFR improvement (average marginal effect [AME], 20.7%; 95% CI, 12.3%–29.1%; p < 0.001) and a reduced risk of AKI (adjusted hazard ratio [HR], 0.53; 95% CI, 0.31–0.88; p = 0.015). In contrast, HIS therapy was associated with a higher risk of GFR deterioration (AME, 10.3%; 95% CI, 2.9%–17.8%; p = 0.006) and increased AKI incidence (adjusted HR, 2.85; 95% CI, 1.52–5.34; p = 0.001), particularly in the early postoperative period.

Conclusion

Statin therapy is associated with improved short-term renal outcomes after TAVR. However, HISs may increase the risk of renal deterioration and AKI. These findings support individualized statin intensity strategies in the periprocedural period to balance cardiovascular benefit and renal safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsAcute Kidney InjuryTranscatheter Aortic Valve ReplacementPostoperative ComplicationsAortic Valve StenosisHumansMaleFemaleRetrospective StudiesGlomerular Filtration RateAged, 80 and overLongitudinal StudiesAgedIncidenceRisk Factors

Stichwörter der Autor:innen

Acute kidney injuryGlomerular filtration rateRenal outcomesStatinsTranscatheter aortic valve replacement

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Heart Center, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University, Jerusalem, Israel.
  • Department of Internal Medicine A, Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Rehovot, Israel.
  • Department of Internal Medicine B, Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Rehovot, Israel.
  • Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Diabetes, Endocrinology and Metabolism, Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Internal Medicine B, Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Rehovot, Israel, a2011z2012z2013@gmail.com.

Zitieren

APA

Abu Khadija, H., Kirzhner, A., Abu Hamdeh, N., Gandelman, G., Ayyad, O., Jofa, L., Haim, A., Cohen, R., Blatt, A., Hassan, A., Mahamid, A., Najajra, D., Nasser, M., Hamdan, Y., Schiller, T., Masu Apos D, M., George, J., & Alnees, M. (2026). Divergent Role of Statin Use and Intensity in Patients Undergoing Transcatheter Aortic Valve Replacement. Cardiorenal Medicine, 16(1), 374-392. https://doi.org/10.1159/000551694

Vancouver

Abu Khadija H, Kirzhner A, Abu Hamdeh N, Gandelman G, Ayyad O, Jofa L, et al. Divergent Role of Statin Use and Intensity in Patients Undergoing Transcatheter Aortic Valve Replacement. Cardiorenal Medicine. 2026;16(1):374-392. doi:10.1159/000551694

BibTeX
@article{AbuKhadija2026,
  author = {Abu Khadija, Haitham and Kirzhner, Alena and Abu Hamdeh, Nizar and Gandelman, Gera and Ayyad, Omar and Jofa, Lilian and Haim, Amir and Cohen, Ramon and Blatt, Alex and Hassan, Adam and Mahamid, Ameer and Najajra, Duha and Nasser, Muhammad and Hamdan, Yazan and Schiller, Tal and Masu Apos D, Mohammad and George, Jacob and Alnees, Mohammad},
  title = {Divergent Role of Statin Use and Intensity in Patients Undergoing Transcatheter Aortic Valve Replacement},
  journal = {Cardiorenal Medicine},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {374--392},
  doi = {10.1159/000551694}
}
Kostenlos starten →